ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 359-368

  Li, Jinghe ^a   Yang, Zhu Lin ^b   Ren, Xuebao ^b   Zou, Qiong ^b   Yuan, Yuan ^b   Liang, Lufeng ^c   Chen, Meigui ^d   Chen, Senlin ^e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Hunan Provincial Second People s Hospital   (China)

^d Loudi Central Hospital   (China)

^e HUNAN CANCER HOSPITAL   (China)

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; Gallbladder cancer; ILK; Metastasis; PRDX1; Prognosis; Squamous cell carcinoma

Indexed keywords

INTEGRIN LINKED KINASE; PEROXIREDOXIN 1;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 84872809562     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0557-2     Document Type: Article

References (29)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010
2. S Jayaraman WR Jarnagin 2010 Management of gallbladder cancer Gastroenterol Clin N Am 39 331 342 10.1016/j.gtc.2010.02.006
3. T Ootani Y Shirai K Tsukada T Muto 1992 Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder Cancer 69 2647 2652 1571894 10.1002/1097-0142(19920601)69:11<2647::AID- CNCR2820691105>3.0.CO;2-0 1:STN:280:DyaK383ktVGnuw%3D%3D
4. JC Roa O Tapia A Cakir O Basturk N Dursun D Akdemir, et al. 2011 Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas Mod Pathol 24 1069 1078 21532545 10.1038/modpathol.2011.68
5. KM Reid A Ramos-De la Medina JH Donohue 2007 Diagnosis and surgical management of gallbladder cancer: a review J Gastrointest Surg 11 671 681 17468929 10.1007/s11605-006-0075-x
6. X de Aretxabala I Roa L Burgos, et al. 2006 Gallbladder cancer: an analysis of a series of 139 patients with restricted to the subserosal layer J Gastrointest Surg 10 186 192 16455449 10.1016/j.gassur.2005.11.003
7. WG Hawkins RP DeMatteo WR Jarnagin L Ben-Porat LH Blumgart Y Fong 2004 Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer Ann Surg Oncol 11 310 315 14993027 10.1245/ASO.2004.03.011
8. AD Durbin GE Hannigan D Malkin 2009 Oncogenic ILK, tumor suppression and all that JNK Cell Cycle 8 4060 4066 19923885 10.4161/cc.8.24.10093 1:CAS:528:DC%2BC3cXotlWqsr8%3D
9. PC McDonald AB Fielding S Dedhar 2008 Integrin-linked kinase-essential roles in physiology and cancer biology J Cell Sci 121 3121 3132 18799788 10.1242/jcs.017996 1:CAS:528:DC%2BD1cXhtlGltrjO
10. V Cortez BC Nair D Chakravarty RK Vadlamudi 2011 Integrin-linked kinase 1: role in hormonal cancer progression Front Biosci (Schol Ed) 3 788 796 10.2741/s187
11. SB Watzka I Rauscher-Pötsch E Stubenberger V Getman U Setinek M Tötsch, et al. 2010 Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection Eur J Cardiothorac Surg 38 254 259 20299233 10.1016/j.ejcts.2010.02.006
12. H Sawai Y Okada H Funahashi Y Matsuo H Takahashi H Takeyama, et al. 2006 Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival Oncogene 25 3237 3246 16407822 10.1038/sj.onc.1209356 1:CAS:528:DC%2BD28XltFWkurc%3D
13. P Intaraprasong K Assi DA Owen DG Huntsman SW Chung CH Scudamore, et al. 2007 Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancer Anticancer Res 27 4371 4376 18214046 1:CAS:528:DC%2BD1cXhtVOlsr0%3D
14. GL Maxwell BL Hood R Day U Chandran D Kirchner VS Kolli, et al. 2011 Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation Gynecol Oncol 121 586 594 21458040 10.1016/j.ygyno.2011.02.031 1:CAS:528:DC%2BC3MXmtl2rsrg%3D
15. I Hoshino H Matsubara Y Akutsu T Nishimori Y Yoneyama K Murakami, et al. 2007 Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients Oncol Rep 18 867 871 17786348 1:CAS:528:DC%2BD2sXhtFygu7jF
16. AC Neumann Q Fang 2007 Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7 375 380 17616437 10.1016/j.coph.2007.04.007 1:CAS:528: DC%2BD2sXpsFKqsrY%3D
17. ST Wen RA Van Etten 1997 The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity Genes Dev 11 2456 2467 9334312 10.1101/gad.11.19.2456 1:CAS:528:DyaK2sXmslajsL8%3D
18. ZM Mu XY Yin EV Prochownik 2002 Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression J Biol Chem 277 43175 43184 12196529 10.1074/jbc.M206066200 1:CAS:528:DC%2BD38Xos1emsrc%3D
19. T Yanagawa S Iwasa T Ishii, et al. 2000 Peroxiredoxin I expression in oral cancer: a potential new tumor marker Cancer Lett 156 27 35 10840156 10.1016/S0304-3835(00)00434-1 1:CAS:528:DC%2BD3cXjslOrurs%3D
20. C Quan EJ Cha HL Lee KH Han KM Lee WJ Kim 2006 Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer J Urol 175 1512 1516 16516038 10.1016/S0022-5347(05) 00659-2 1:CAS:528:DC%2BD28XjtlWku7s%3D
21. KH Chung DH Lee Y Kim TH Kim JH Huh SG Chung, et al. 2010 Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma J Proteome Res 9 451 457 19902980 10.1021/pr900811x 1:CAS:528:DC%2BD1MXhsV2nur3K
22. JH Kim PN Bogner SH Baek N Ramnath P Liang HR Kim, et al. 2008 Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target Clin Cancer Res 14 2326 2333 18413821 10.1158/1078-0432.CCR-07-4457 1:CAS:528:DC%2BD1cXkvFGmtLs%3D
23. I Hoshino H Matsubara Y Akutsu T Nishimori Y Yoneyama K Murakami, et al. 2007 Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients Oncol Rep 18 867 871 17786348 1:CAS:528:DC%2BD2sXhtFygu7jF
24. DC Liu ZL Yang S Jiang 2010-2011 Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma Cancer Biomark 8 113 121 1:CAS:528:DC%2BC3MXhsFaitb7L
25. K Nishihara E Nagai Y Izumi, et al. 1994 Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases Jpn J Cancer Res 85 389 399 7911122 10.1111/j.1349-7006. 1994.tb02372.x 1:STN:280:DyaK2c3lvFKmsQ%3D%3D
26. M Kondo K Dono M Sakon, et al. 2002 Adenosquamous carcinoma of the gallbladder Hepatogastroenterology 49 1230 1234 12239911
27. V Cortez BC Nair D Chakravarty RK Vadlamudi 2011 Integrin-linked kinase 1: role in hormonal cancer progression Front Biosci (Schol Ed) 3 788 796 10.2741/s187
28. JR Graff JA Deddens BW Konicek BM Colligan BM Hurst HW Carter, et al. 2001 Integrin-linked kinase expression increases with prostate tumor grade Clin Cancer Res 7 1987 1991 11448915 1:STN:280:DC%2BD3MzpslensQ%3D%3D
29. MT Prosperi D Ferbus I Karczinski G Goubin 1993 A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins J Biol Chem 268 11050 11056 8496166 1:CAS:528:DyaK3sXks1Cltb0%3D